Born from a problem raised by French urologists, Stimuli Technology was created in 2018 by Technofounders. Its mission is to improve the lives of patients with overactive bladder syndrome through technology based on transcutaneous electrical nerve stimulation, more commonly known as TENS (Transcutaneous Electrical Nerve Stimulation).
Overactive bladder is a clinical syndrome that affects both men and women today and can occur at any age. It is mainly manifested by the frequent, sudden and uncontrollable urge to urinate; these symptoms can occur at any time of the day or night.
Studies have shown that 15% * of the population is affected by overactive bladder syndrome, which is now underdiagnosed.
To meet this need, Stimuli Technology has developed Tensi +, a device for the treatment of overactive bladder. This non-invasive bracelet placed on the passage of the posterior tibial nerve sends electrical stimulation through electrodes located on the skin.
Following the obtaining of the CE marking according to the new European regulation MDR2017 / 745, the Tensi + medical device is now introduced on the market. The challenge for Stimuli Technology in the coming months is to inform patients with this syndrome that treatments are available that can improve their quality of life.
* Marcelissen T, et al. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment ?. Eur Urol Focus (2018), https://doi.org/10.1016/j.euf.2018.05.004